{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:11:33Z","timestamp":1761894693384},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2008,2,1]],"date-time":"2008-02-01T00:00:00Z","timestamp":1201824000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2008,2]]},"DOI":"10.1007\/s10072-008-0857-x","type":"journal-article","created":{"date-parts":[[2008,3,31]],"date-time":"2008-03-31T11:50:02Z","timestamp":1206964202000},"page":"37-39","source":"Crossref","is-referenced-by-count":22,"title":["Infratentorial progressive multifocal leukoencephalopathy in a patient treated with fludarabine and rituximab"],"prefix":"10.1007","volume":"29","author":[{"given":"Simona","family":"Bonavita","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renata","family":"Conforti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Russo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rosaria","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Tessitore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marida","family":"Della Corte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rosaria","family":"Monsurr\u00f2","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gioacchino","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,1]]},"reference":[{"key":"857_CR1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/brain\/81.1.93","volume":"81","author":"K.E. Astrom","year":"1958","unstructured":"Astrom KE, Mancall EL, Richardson Jr EP (1958) Progressive multifocal leukoencephalopathy: a hitherto unrecognised complication of chronic lymphatic leukaemia and Hodgkin\u2019s disease. Brain 81:93\u2013111","journal-title":"Brain"},{"key":"857_CR2","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1056\/NEJMoa051586","volume":"353","author":"G. Assche Van","year":"2005","unstructured":"Van Assche G, Van Ranst M, Sciot R et al (2005) Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn\u2019s disease. N Engl J Med 353:362\u2013368","journal-title":"N Engl J Med"},{"key":"857_CR3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"B.K. Kleinschmidt-DeMasters","year":"2005","unstructured":"Kleinschmidt-DeMasters BK, Tyler KL (2005) Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 353:369\u2013374","journal-title":"N Engl J Med"},{"key":"857_CR4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A. Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ et al (2005) Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 353:375\u2013381","journal-title":"N Engl J Med"},{"key":"857_CR5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajh.20492","volume":"80","author":"J. Garcia-Suarez","year":"2005","unstructured":"Garcia-Suarez J, de Miguel D, Krsnik I et al (2005) Changes in the natural history of progressive multifocal leukoencephalopathy in HIV-negative lymphoproliferative disorders: impact of novel therapies. Am J Hematol 80:271\u2013281","journal-title":"Am J Hematol"},{"key":"857_CR6","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.clineuro.2004.10.005","volume":"107","author":"O. Kastrup","year":"2005","unstructured":"Kastrup O, Wanke I, Esser S, Maschke M (2005) Evolution of purely infratentorial PML under HAART-negative outcome under rapid immune reconstitution. Clin Neurol Neurosurg 107:509\u2013513","journal-title":"Clin Neurol Neurosurg"},{"key":"857_CR7","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ana.1004","volume":"49","author":"F. Weber","year":"2001","unstructured":"Weber F, Goldmann C, Kramer M et al (2001) Cellular and humoral immune response in progressive multifocal leukoencephalopathy. Ann Neurol 49:636\u2013642","journal-title":"Ann Neurol"},{"key":"857_CR8","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1517\/14728222.10.4.489","volume":"10","author":"Y.Y. Li","year":"2006","unstructured":"Li YY, Perez HD, Zollner TM (2006) Fatalities in natalizumab treatment \u2014 a \u2018no go\u2019 for leukocyte recirculation approaches? Expert Opin Ther Targets 10:489\u2013499","journal-title":"Expert Opin Ther Targets"},{"key":"857_CR9","doi-asserted-by":"crossref","first-page":"559","DOI":"10.7326\/0003-4819-129-7-199810010-00010","volume":"129","author":"E.J. Anaissie","year":"1998","unstructured":"Anaissie EJ, Kontoyiannis DP, O\u2019Brien S et al (1998) Infections in patients with chronic lymphocytic leukemia treated with fludarabine. Ann Intern Med 129:559\u2013566","journal-title":"Ann Intern Med"},{"key":"857_CR10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1182\/blood-2002-04-1271","volume":"100","author":"P. Matteucci","year":"2002","unstructured":"Matteucci P, Magni M, Di Nicola M et al (2002) Leukoencephalopathy and papova virus infection after treatment with chemotherapy and anti-CD20 monoclonal antibody. Blood 100:1104\u20131105","journal-title":"Blood"},{"key":"857_CR11","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1128\/JCM.34.12.2929-2932.1996","volume":"34","author":"A.L. Hammarin","year":"1996","unstructured":"Hammarin AL, Bogdanovic G, Svedem V et al (1996) Analysis of PCR as a tool for detection of JC Virus DNA in cerebrospinal fluid for diagnosis of progressive multifocal leukoencephalopathy. J Clin Microbiol 34:2929\u20132932","journal-title":"J Clin Microbiol"},{"key":"857_CR12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"G.F. Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA et al (2004) The human poly-omavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380\u20131383","journal-title":"Science"},{"key":"857_CR13","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.mehy.2005.01.037","volume":"65","author":"E.L. Altschuler","year":"2005","unstructured":"Altschuler EL, Kast RE (2005) The atypical antipsychotic agents zisprasidone, risperdone and olanzapine as treatment for and prophylaxis against progressive multifocal leukoencephalopathy. Med Hypotheses 65:585\u2013586","journal-title":"Med Hypotheses"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0857-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-008-0857-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-008-0857-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,3]],"date-time":"2020-05-03T16:00:50Z","timestamp":1588521650000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-008-0857-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,2]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,2]]}},"alternative-id":["857"],"URL":"https:\/\/doi.org\/10.1007\/s10072-008-0857-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,2]]}}}